Ventricular dysfunction or structural alteration of either ventricle is a well-established risk factor for sudden death (SD). Ebstein anomaly (EA) can present with both right and left heart abnormalities; however, predictors of SD have not been described. We therefore sought to characterize the incidence and risk factors of SD among a large cohort of patients with EA. 
Introduction
Ebstein anomaly (EA) can present with a broad continuum of clinical severity based on the degree of right ventricular (RV) and tricuspid valve (TV) dysfunction. Surgery is not uncommonly required, as is therapy for atrial and supraventricular arrhythmias. 1 Accessory pathway mediated-tachycardia is typically recognized early in the disease course, given its association with symptomatic palpitations, baseline electrocardiographic abnormalities, and the frequency of preoperative electrophysiology studies (EPS). 2, 3 However, sudden death (SD) from malignant ventricular arrhythmias can present without any prodrome and is distinctly understudied in this patient subgroup. 4 Right ventricular dilatation and dysfunction, prior cardiac operations, sinus nodal dysfunction, intra-atrial conduction block, and atrioventricular conduction abnormalities are all recognized associations with this form of cardiomyopathy-all of which may contribute to SD. 1, 5, 6 Although ventricular arrhythmias have been well characterized in acquired heart diseases, and some congenital heart disease (CHD) such as tetralogy of Fallot (TOF), the incidence and risk factors for SD in EA have not been clearly defined. 7 We therefore aimed to: (i) determine the incidence of SD in a large cohort of EA patients seen in our institution and (ii) identify risk factors associated with SD in this patient group.
Methods

Patient population
All patients seen at the Mayo Clinic with a confirmed diagnosis of EA between April 1972 and 31 December 2015 were retrospectively reviewed. Inclusion criteria were atrioventricular and ventriculo-arterial concordance and two ventricles. Exclusion criteria were: pulmonary atresia with intact ventricular septum; complex conotruncal abnormalities; and congenitally corrected transposition of the great arteries (ccTGA). Written informed consent was obtained for all participating patients. The study was in compliance with the principles outlined in the Declaration of Helsinki, and its ethics aspects were reviewed and approved by the Mayo Clinic Institutional Review Board.
Data review
A combination of paper and electronic medical records for included patients were reviewed. Demographics and pertinent clinical historiessyncope, family history of SD, family history of CHD, heart failure, cyanosis (blue discoloration or oxygen saturation <85%), coronary artery disease (CAD), diabetes, hypertension, and hyperlipidaemia-were recorded. Atrial, ventricular [ventricular tachycardia/fibrillation (VT/VF)], and accessory pathway arrhythmias were documented based on available telemetry, Holter ECG, electrocardiographic, and EPS data. Baseline echocardiographic parameters gathered included: EA anatomic severity (based on extent of septal displacement); qualitative assessments of RV size and function; extent of tricuspid regurgitation (TR) and mitral regurgitation (MR); presence of pulmonic stenosis (PS); intracardiac shunts e.g. atrial septal defect (ASD), patent foramen ovale (PFO), ventricular septal defect (VSD); and left ventricular ejection fraction (LVEF) quantification via visual estimate or biplane Simpson method. Haemoglobin levels, either pre-operatively or at last follow-up (for patients who did and did not undergo surgery respectively), were recorded. For patients who underwent TV surgical intervention, details on the procedures performed were recorded. These included: type of TV surgery performed (repair vs. replacement); intraoperative Maze (right-sided vs. bi-atrial); atrialized RV (ARV) plication; right reduction atrioplasty; and intracardiac shunt repair. Perioperative (defined as period of hospitalization following surgery) ventricular arrhythmia events or conduction abnormalities requiring permanent pacemaker (PPM) implantation were documented as well.
For patients who underwent ICD implantation either prior to or following their evaluation at our institution, indications for implantation (primary vs. secondary prevention) and inappropriate/appropriate shocks were recorded.
Assessment of clinical outcome
Sudden death was defined as: (i) witnessed sudden death; (ii) sustained (>30 s) VT/VF; (iii) resuscitated out-of-hospital arrest; (iv) appropriate implantable cardioverter-defibrillator (ICD) discharge (ventricular antitachycardia pacing or shock delivery); (v) unwitnessed death with autopsy or death certificate consistent with SD. Rhythm strips and ICD intracardiac electrograms were reviewed by C.A.J. and C.J.M. to confirm the presence of a sustained ventricular arrhythmia. Death certificates and autopsy reports were also sought for all patients. Dates for confirmed SD events that occurred prior to or following evaluation at our institution were documented.
Statistical analysis
The cumulative incidence of SD from birth in the included cohort was estimated using the Kaplan-Meier method; for patients who suffered multiple SD events, the first episode was used. Cox proportional hazards regression modelling was implemented to evaluate potential risk factors for development of SD. Univariable regression analyses of clinical characteristics and echocardiographic/structural parameters were completed. A multivariable model was then constructed based on the exploratory univariable analysis results and data from prior clinical studies assessing mortality/arrhythmia risk factors associated with EA. [4] [5] [6] Given that TV surgery is a function of time after initial evaluation, it was included as a time-dependent covariate in both univariable and multivariable models. A subgroup analysis of the patients who underwent TV surgery at our institution was also completed. The unadjusted incidence of SD following surgery was estimated with the Kaplan-Meier method. Univariable Cox proportional hazards regression modelling was completed to: (i) determine associations between time-to-SD post-surgery and surgical procedures performed as well as perioperative VT events and conduction abnormalities necessitating device implantation; (ii) verify that the predictors identified in the combined cohort analysis remained significant in the surgery subgroup. The final multivariable model was created based on the results from the multivariable analysis in the whole cohort.
The expected rate of SD was constructed using age and genderspecific SD incidences from data reported in the CPR Chicago Project. 8 The estimated expected SD numbers were compared to our observed rates using a one-sample log-rank test.
All described statistical analyses were performed using SAS version 9.4 (Cary, NC, USA).
Results
Baseline characteristics of study cohort and univariable associations with sudden death Nine hundred and sixty-eight patients were included in the analysis; mean follow-up time was 13.2 years [standard deviation (STD) 10.5 years]. The mean age of patients seen on initial evaluation was 25.3 years (STD 18.8 years); 41.5% were male ( Table 1) . A considerable number of patients had undergone cardiovascular surgeries previously (n = 265, 27.4%), transcatheter pulmonary valve interventions (n = 7, 0.7%) and ASD/PFO (n = 10, 1.0%) device closures were reported rarely. Many had prior histories of syncope and heart failure (17.1% and 22.3%, respectively). Accessory pathway and atrial arrhythmias were noted in 178 (18.6%) and 285 (29.9%) patients, respectively. Fifty-nine patients (6.1%) had prior ventricular arrhythmia events; of these, seven suffered SD. Seven (0.74%) and 29 (3.0%) patients had histories of ICD and PPM implantations, respectively. Atherosclerotic disease and traditional cardiovascular risk factors (i.e. hypertension, hyperlipidaemia etc.) were not common. Most patients had severe EA anatomic severity (n = 772, 79.8%), TR (n = 791, 82.1%), and RV enlargement (n = 649, 69.4%) with at least a moderate degree of RV dysfunction (n = 572, 74.7%). Intracardiac shunts were common as well, with 580 (59.9%), 180 (18.6%), and 58 (6.0%) of patients having ASD, PFO, and VSD, respectively. A minority of patients were noted to have PS (n = 67, 6.9%), LV non-compaction Exploratory univariable Cox regression analyses showed increased SD risk associations with syncope [hazard ratio (HR) 2.59, P < 0.001], heart failure (HR 5.69, P < 0.001), unoperated haemoglobin > 15 g/dL (HR 2.54, P = 0.003), CAD (HR 2.39, P = 0.031), and atrial arrhythmias (HR 1.74, P = 0.036). Histories of VT (HR 6.08, P < 0.001) and ICD implantation (HR 7.94, P = 0.004) were associated with an increased SD risk as well. Additionally, mean QRS duration was significantly associated with SD (HR 1.01, P = 0.003). In terms of echocardiographic parameters, RV dysfunction (overall P = 0.020) but not EA anatomic severity and RV size were associated with increased SD risk. PS (HR 2.30, P = 0.021) and MR (overall P = 0.042) also showed positive associations with SD risk.
Incidence of sudden death throughout life among Ebstein anomaly patients
Take home figure illustrates the incidence of SD from birth in the study cohort with corresponding 95% confidence intervals (95% CI). The 10-, 20-, 50-, and 70-year risk of SD were 0.8%, 1.9%, 8.3%, and 14.6%, respectively. Sudden death rates observed in the study cohort were significantly higher than expected estimated using age-and gender-specific data from a non-EA population (Supplementary material online, Figure S1 ).
In terms of index SD events, 31 had witnessed SD, 10 had sustained VT/VF, 10 experienced resuscitated out-of-hospital arrests, and 14 had unwitnessed deaths with autopsy reports or death certificates that were consistent with SD. Additionally, seven patients had appropriate ICD discharges following their initial SD event.
Multivariable Cox proportional hazards modelling of predictors associated with sudden death A prior study of outcomes following surgical intervention for EA revealed elevated haemoglobin/haematocrit levels and PS as predictors for mortality 4 ; haemoglobin > 15 g/dL and PS were therefore included in the multivariable model. Other added variables were heart failure, prior VT, syncope, and TV surgery. Table 2 summarizes the adjusted HRs and their corresponding CIs as well as P-values for the abovementioned variables. All remained statistically significant following multivariable adjustment.
Incidence of sudden death following tricuspid valve surgery Figure 1 illustrates the Kaplan-Meier estimated incidence of SD following TV surgery. Sudden death risk was 2.2% 1-year post-surgery; Information was unavailable regarding age at first visit (n = 15), heart failure (n = 12), syncope (n = 21), final cyanosis ever (n = 5), CAD (n = 30), Hb (n = 70), final family history of SD (n = 41), final family history of CHD (n = 36), prior PV surgery (n = 2), age at first prior cardiovascular surgery (n = 13), prior transcatheter ASD closure (n = 4), accessory pathway (n = 12), atrial arrhythmia (n = 16), QRS interval (n = 107), QTc (n = 121), final RV function (n = 98), RV size (n = 33), TR (n = 5), MR (n = 6), and LVEF (n = 1 Investigation of associations between sudden death and cardiovascular surgical procedures performed Table 3 summarizes the surgical procedures performed in tandem with TV surgery. Four hundred and ninety-one patients (61.1%) underwent TV replacement. Most had concomitant interatrial communication closures (n = 545, 69.3%) and right reduction atrioplasties (n = 557, 69.3%), whereas a smaller number received ARV plication (n = 291, 36.2%) and intraoperative Maze procedures (n = 135, 16.8%). A subset of patients required perioperative PPM placement (n = 40, 5.0%) primarily for atrioventricular heart block. Overall, most of the interventions were not significantly associated with SD risk. However, bi-atrial Maze had an 18.41-fold increased risk of SD in comparison with right-sided Maze (P = 0.002).
Subgroup analysis: Cox proportional hazards modelling of predictors associated with post-operative sudden death
Univariable regression analysis of the subgroup of patients who underwent TV surgery demonstrated that heart failure, syncope, prior VT, haemoglobin > 15 g/dL, and PS were significantly associated with SD risk (Table 4) . Apart from syncope, the association between SD and these variables remained statistically significant with multivariable modelling.
Implantable cardioverter-defibrillator indications and shocks delivered
Twnety-four patients underwent ICD implantation, either prior to or following evaluation at our institution ( Table 5) . Fourteen patients received an ICD for secondary prevention. Of these, seven patients had appropriate shocks for ventricular arrhythmias, while three received inappropriate shocks (usually for atrial tachycardias). Ten patients underwent primary prevention ICD implantation for the following reasons: LVEF < 35% (n = 1); perioperative VT (n = 1); nonsustained ventricular tachycardia noted on telemetry or pacemaker interrogation (n = 2); VT induced on electrophysiologic study (n = 3); severe RV enlargement with global akinesis (n = 1); multiple unexplained syncopal episodes with concomitant LV non-compaction (n = 1); and strong family history of SD (n = 1). None of these patients received appropriate shocks and four received inappropriate shocks.
Discussion
Ebstein anomaly is an uncommon CHD and investigations of SD among such patients are limited by small sample sizes at each 2, 7 These findings originate from the largest cohort of EA patients described to date, and several important observations are evident: (i) there is a tangible risk for SD in patients with EA throughout their lifetimes; (ii) key clinical variables including the presence of heart failure, prior VT events, and PS are significant risk factors for SD; (iii) SD may occur shortly after surgery but this risk persists at a relatively linear rate many years afterwards; and (iv) Biatrial Maze procedures may be associated with increased SD risk. The incidence of SD in the general CHD population is relatively low at <0.1%/year; however, malignant ventricular events are much more commonly seen in patients with specific types of CHD such as TOF and ccTGA. 9, 10 In the current study, the 70-year risk of SD among the participating EA cohort was approximately 15%; assuming linearity, this would approximate to an incidence of 0.2%/year, which is comparable to that seen in TOF and certainly higher than what would be expected in a non-EA population of a similar age and gender makeup. Interestingly, this finding mirrors results from an older study that analysed arrhythmia outcomes in 52 post-operative EA patients, where three SD events were noted in a 33-month followup period.
11
Prior heart failure and VT episodes were associated with significant elevations in SD risk. A key question to be asked in this context is whether those who succumb to sudden death are simply an inherently sicker group of patients. Intuitively, sicker patients are more likely to die but this is not necessarily the case with other CHD syndromes as it relates to sudden death vs. other cardiac causes of death. Reentrant ventricular arrhythmias or acute bradycardic events are commonly scar related and can occur in young patients with preserved ventricular function.
Exploratory and multivariable analyses revealed significant associations between clinical/laboratory parameters and SD among our EA population. Although the prevalence of CAD was low given the young age of the study cohort, it appears to be an important predictor of future SD events. A known risk factor for SD in the general population, [12] [13] [14] this recapitulates the differences in managing adult CHD patients as opposed to their paediatric counterparts. The presence of atrial arrhythmias was also univariably associated with SD and deserves further investigation in a more focused study. Pulmonic stenosis, occasionally seen in patients with EA, 2,15 may lead to increased RV pressures and strain 16 ; in addition, a multi-centre study conducted in Europe found that EA patients with pulmonary valve defects had an increased risk of long-term mortality. 17 The combination of PS and RV dysfunction has been shown to be arrhythmogenic as well, with significant effects on ventricular refractoriness and repolarization. 18 Furthermore, surgical repair of PS results in RV fibrosis and discrete conduction obstacles, which not only can impact the homogeneity of repolarization, but can also contribute further to the risk of SD via scar-related effects on conduction and depolarization velocity. 19 Elevations in haemoglobin/haematocrit levels were noted to be positively associated with mortality following TV surgical intervention in EA patients. 20 Although the mechanism for this is currently unclear, it is possible that those patients have an element of cyanosis with correspondingly poorer RV function, higher RA pressures, and worse pulmonary perfusion. QRS duration >180 ms as well as severe TR and RV enlargement are recognized risk factors for SD among TOF patients. 21 Interestingly, although RV dysfunction exhibited a dose-dependent relationship with SD risk, the extent of TR and RV enlargement were not significantly predictive of future SD events in the studied EA cohort. Right ventricular structural and functional assessment is notoriously difficult to assess accurately, given its crescentic shape in the normal heart and dependence on LV septal motion. As such, conventional two-dimensional echocardiography may not be adequate in evaluating RV status, which in turn impacts its ability to predict future SD. Advanced imaging techniques such as three-dimensional echocardiography and cardiac magnetic resonance may allow for more reliable determination of RV size and function. 22 It would therefore be interesting to see how the relationship between RV status and SD risk changes in future studies which incorporate these newer modalities.
Although surgical repair of complex congenital cardiac lesions is often necessary to restore haemodynamic stability and improve symptoms, the potential risk for arrhythmogenic foci creation (through the procedures themselves as well as subsequent remodelling) is well recognized. 4, 11, 23, 24 The possibility of post-operative SD should therefore be considered, particularly among individuals with risk factors as discussed above (and highlighted in Table 4 ). The 1-year risk of SD following TV surgery for EA in our study was 2.0%. Although the rise in SD risk tapered somewhat after the first few years post-surgery, the incidence of SD remained relatively steady over the next few decades. Regular surveillance of post-surgical EA patients is therefore warranted as the risk for SD appears likely to persist for years to come. A large proportion of patients who underwent TV surgery at our institution also received concomitant intracardiac procedures for various indications including shunt closure and arrhythmia ablation. In general, these procedures did not demonstrate an increased risk of SD post-surgery. However, it is interesting to note that bi-atrial Maze was more strongly associated with SD compared to right-sided Maze. Patients who had bi-atrial Maze were more likely to have higher atrial arrhythmia burden and cardiovascular comorbidities; in addition, a more aggressive ablation approach has been associated with a higher incidence of pacemaker implant-hinting that the mechanism of SD in this subgroup is potentially related to sinus or AV nodal failure in aetiology. 25 A total of 24 patients in the present study underwent ICD implantation for malignant ventricular arrhythmia prevention. Half of the patients in the secondary prevention subgroup received appropriate ICD shocks. On the other hand, none of the patients in the primary prevention subgroup sustained appropriate shocks. This exposes current limitations to accurately predict EA patients at risk of a primary SD event. As there are no guidelines for ICD implantation specific to EA, 21 the data gathered in this study can help guide future prospective studies aimed at clarifying the use and outcomes of ICDs in the EA population (e.g. creation and validation of a SD risk calculator specific to EA patients utilizing predictors identified in the present study).
Limitations
While all attempts to identify the cause of death were made, not all sudden death is necessarily sudden arrhythmic death. This remains a limitation of all sudden death studies, but in these cases the family was contacted and all available autopsy reports carefully reviewed. Additionally, some data could not be retrieved from available records, inadvertently resulting in missing data, which could have affected the accuracy and precision of the computed HRs. No data on cardiopulmonary testing or brain natriuretic peptide (BNP) levels were recorded, limiting our ability to determine associations between SD and these parameters. The study was retrospective and non-randomized, and thus there is the potential for confounding by other clinical variables that were unaccounted for. There is also an element of referral bias as a large proportion of patients are referred to this quaternary referral centre with severe disease. Hence, the incidence of SD observed may be an overestimation of what may be seen in the general EA population. In relation to this, the majority of the patients in the present study, particularly those with severe disease, underwent surgical intervention. The disparity in numbers between operated and unoperated patients, as well as the intrinsic differences in disease severity and comorbidities, made it statistically unfeasible to compare outcomes between them. Finally, substantial refinements in management, evaluation, and surgical techniques took place during the course of the study period; consequently, the impact of identified risk factors on SD risk could have been altered over time.
Despite the aforementioned challenges, the present study represents the largest investigation of SD in EA patients thus far, and the data shown may be critical in reducing the impact of SD among these individuals.
Conclusion
Patients with EA are at significant risk for SD throughout their lifetimes; and this is in keeping with other complex forms of CHD that are associated with ventricular dysfunction. Key clinical parameters including pulmonary stenosis, heart failure, and prior syncope or VT are strongly predictive of future SD events, supporting the notion of ventricular arrhythmias being the most likely trigger. These findings can guide discussions with EA patients regarding their risk profile for SD and also aid in the deliberation regarding which patients should receive ICDs as primary prevention.
